New Jersey

Genta Incorporated is a biopharmaceutical company focused on the identification, development and commercialization of drugs for the treatment of people with cancer. Genta has built a broad portfolio of proprietary products in various stages of clinical development. The Company’s drugs include Ganite (gallium nitrate injection), tesetaxel, and oral gallium. Genta is committed to developing innovative products to better the lives of people with cancer.

In August 2012 the company filed for bankruptcy.